Abstract

AIDS Patient Care and STDsVol. 21, No. 9 Antiviral BriefsPublished Online:5 Oct 2007https://doi.org/10.1089/apc.2007.9970AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byLogistic Regression Classifiers in the Analysis of HIV-1 Use of CCR5 and CXCR4 Coreceptors4 June 2019Journal of Natural Medicines, Vol. 71, No. 4Increased CXCR4 Use of HIV-1 Subtype C Identified by Population Sequencing in Patients Failing Antiretroviral Treatment Compared with Treatment-Naive Patients in Botswana Lotta Pramanik Sollerkvist, Simani Gaseitsiwe, Madisa Mine, Gaseene Sebetso, Thongbotho Mphoyakgosi, Thabo Diphoko, Max Essex, and Anneka Ehrnst2 May 2014 | AIDS Research and Human Retroviruses, Vol. 30, No. 5Determination of HIV tropism and its use in the clinical practice10 January 2014 | Expert Review of Anti-infective Therapy, Vol. 11, No. 12When and how to use maraviroc in HIV-infected patientsAIDS, Vol. 23, No. 18HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs1 April 2009 | Antiviral Chemistry and Chemotherapy, Vol. 19, No. 5Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists5 March 2009 | Journal of Antimicrobial Chemotherapy, Vol. 63, No. 5Optimal use of maraviroc in clinical practiceAIDS, Vol. 22, No. 17Maraviroc: farmacocinética, interacciones y mecanismo de acciónEnfermedades Infecciosas y Microbiología Clínica, Vol. 26Métodos de determinación del tropismo viral: tests genotípicos y fenotípicosEnfermedades Infecciosas y Microbiología Clínica, Vol. 26A sensitive HPLC–MS–MS method for the determination of raltegravir in human plasmaJournal of Chromatography B, Vol. 867, No. 2 Volume 21Issue 9Sep 2007 InformationMary Ann Liebert, Inc.To cite this article:Antiviral Briefs.AIDS Patient Care and STDs.Sep 2007.702-705.http://doi.org/10.1089/apc.2007.9970Published in Volume: 21 Issue 9: October 5, 2007PDF download

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.